Skip to main content
logo
Climb Bio, Inc. (CLYM)
NASDAQ: CLYM · Real-Time Price · USD
11.43
-0.04 (-0.35%)
Oct 1, 2026, 2:36 PM EDT - Market open

Climb Bio Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Oct '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Market Capitalization
6561911217498278
Market Cap Growth
386.83%57.83%62.54%-23.65%-64.90%-
Enterprise Value
41916-97-33-32108
Last Close Price
11.474.001.802.703.6710.46

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Oct '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PB Ratio
2.751.190.570.690.761.66
P/TBV Ratio
2.741.190.570.690.761.66

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Oct '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Debt / Equity Ratio
0.010.000.000.000.00-
Net Debt / Equity Ratio
-0.99-1.00-1.00-0.99-0.96-0.96
Net Debt / EBITDA Ratio
3.682.36----
Net Debt / FCF Ratio
4.482.9413.625.173.294.47
Quick Ratio
30.8614.4730.6138.5721.3523.79
Current Ratio
31.4515.1631.4138.9222.0424.58
Return on Equity (ROE)
-27.10%-32.15%-46.26%-29.72%-30.58%-50.16%
Return on Assets (ROA)
-18.45%-22.04%-10.30%-10.93%-18.30%-22.54%
Return on Capital Employed (ROCE)
-26.90%-42.20%-12.70%-19.90%-35.00%-21.30%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Oct '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Earnings Yield
-8.78%-31.34%-61.07%-47.17%-46.40%-17.09%
FCF Yield
-8.08%-28.56%-12.86%-27.67%-38.33%-12.99%
Buyback Yield / Dilution
-2.38%-40.80%-78.47%-2.57%-114.60%-460.40%
SEC Filings: 10-K · 10-Q